Browsing by Author "Fuentes-Rivera, H"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
Publication Últimos avances en el tratamiento neoadyuvante de cáncer de vejiga(Colegio Medico del Peru, 2022) Rioja, P; Valencia, G; Morante, Z; Paz, R; Vallejos, H; Fuentes-Rivera, H; Neciosup, SCisplatin-based neoadjuvant therapy has shown clear benefits in clinical stage II or IIIA muscle invasive bladder cancer (MIBC), achieving an impact in progression-free survival and overall survival. This updated review focuses on neoadjuvant therapy for MIBC, including the current recommendations from international and/or local practice guidelines, as well as studies of new therapeutic agents (immunotherapy, targeted therapy), on top of research on potential biomarkers that may predict response to immunotherapy. © 2022 Acta Medica Peruana. All rights reserved.